View in EDS

ID2 Suppresses Multiple Myeloma Cell Proliferation by Repressing the Activity of the Transcription Factor TCF3.

Saved in:
Bibliographic Details
Title: ID2 Suppresses Multiple Myeloma Cell Proliferation by Repressing the Activity of the Transcription Factor TCF3.
Authors: Fulciniti M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Yao Y; Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou Medical University, Xuzhou, China., Perini T; Laboratory of Age Related Diseases, Division of Genetics and Cell Biology and Hematology and Bone Marrow Transplantation Unit, IRCCS Ospedale San Raffaele, Milan, Italy., Fong Ng J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Schavgoulidze A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Deng S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China., Cui J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Encinas Mayoral J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Ladisa F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Young RM; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Epstein CB; The Broad Institute of the Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts., White CM; The Broad Institute of the Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts., Ott CJ; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Charlestown, Massachusetts., Gulla A; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Matulis SM; Department of Hematology and Medical Oncology and the Winship Cancer Institute at Emory University, Atlanta, Georgia., Sperling AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology, Brigham and Women's Hospital, Boston, Massachusetts., Morelli E; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Oncology, University of Torino, Candiolo, Italy., Boise LH; Department of Hematology and Medical Oncology and the Winship Cancer Institute at Emory University, Atlanta, Georgia., Binder M; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Szalat R; Department of Hematology and Medical Oncology, Boston University Medical Center, Boston, Massachusetts., Samur MK; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Anderson KC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Munshi NC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; VA Boston Healthcare System, Boston, Massachusetts.
Source: Blood cancer discovery [Blood Cancer Discov] 2026 Jan 12; Vol. 7 (1), pp. 129-141.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41104834
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: ID2 Suppresses Multiple Myeloma Cell Proliferation by Repressing the Activity of the Transcription Factor TCF3.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fulciniti+M%22">Fulciniti M</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Yao+Y%22">Yao Y</searchLink>; Blood Diseases Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou Medical University, Xuzhou, China.<br /><searchLink fieldCode="AU" term="%22Perini+T%22">Perini T</searchLink>; Laboratory of Age Related Diseases, Division of Genetics and Cell Biology and Hematology and Bone Marrow Transplantation Unit, IRCCS Ospedale San Raffaele, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Fong+Ng+J%22">Fong Ng J</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Schavgoulidze+A%22">Schavgoulidze A</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Deng+S%22">Deng S</searchLink>; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Cui+J%22">Cui J</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Encinas+Mayoral+J%22">Encinas Mayoral J</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Ladisa+F%22">Ladisa F</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Young+RM%22">Young RM</searchLink>; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Epstein+CB%22">Epstein CB</searchLink>; The Broad Institute of the Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22White+CM%22">White CM</searchLink>; The Broad Institute of the Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Ott+CJ%22">Ott CJ</searchLink>; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Charlestown, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Gulla+A%22">Gulla A</searchLink>; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.<br /><searchLink fieldCode="AU" term="%22Matulis+SM%22">Matulis SM</searchLink>; Department of Hematology and Medical Oncology and the Winship Cancer Institute at Emory University, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22Sperling+AS%22">Sperling AS</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology, Brigham and Women's Hospital, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Morelli+E%22">Morelli E</searchLink>; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Oncology, University of Torino, Candiolo, Italy.<br /><searchLink fieldCode="AU" term="%22Boise+LH%22">Boise LH</searchLink>; Department of Hematology and Medical Oncology and the Winship Cancer Institute at Emory University, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22Binder+M%22">Binder M</searchLink>; Division of Hematology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Szalat+R%22">Szalat R</searchLink>; Department of Hematology and Medical Oncology, Boston University Medical Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Samur+MK%22">Samur MK</searchLink>; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Anderson+KC%22">Anderson KC</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Munshi+NC%22">Munshi NC</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; VA Boston Healthcare System, Boston, Massachusetts.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101764786%22">Blood cancer discovery</searchLink> [Blood Cancer Discov] 2026 Jan 12; Vol. 7 (1), pp. 129-141.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101764786 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2643-3249 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226433230%22">26433230 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer Discov <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41104834
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/2643-3230.BCD-25-0048
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 129
    Titles:
      – TitleFull: ID2 Suppresses Multiple Myeloma Cell Proliferation by Repressing the Activity of the Transcription Factor TCF3.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fulciniti M
      – PersonEntity:
          Name:
            NameFull: Yao Y
      – PersonEntity:
          Name:
            NameFull: Perini T
      – PersonEntity:
          Name:
            NameFull: Fong Ng J
      – PersonEntity:
          Name:
            NameFull: Schavgoulidze A
      – PersonEntity:
          Name:
            NameFull: Deng S
      – PersonEntity:
          Name:
            NameFull: Cui J
      – PersonEntity:
          Name:
            NameFull: Encinas Mayoral J
      – PersonEntity:
          Name:
            NameFull: Ladisa F
      – PersonEntity:
          Name:
            NameFull: Young RM
      – PersonEntity:
          Name:
            NameFull: Epstein CB
      – PersonEntity:
          Name:
            NameFull: White CM
      – PersonEntity:
          Name:
            NameFull: Ott CJ
      – PersonEntity:
          Name:
            NameFull: Gulla A
      – PersonEntity:
          Name:
            NameFull: Matulis SM
      – PersonEntity:
          Name:
            NameFull: Sperling AS
      – PersonEntity:
          Name:
            NameFull: Morelli E
      – PersonEntity:
          Name:
            NameFull: Boise LH
      – PersonEntity:
          Name:
            NameFull: Binder M
      – PersonEntity:
          Name:
            NameFull: Szalat R
      – PersonEntity:
          Name:
            NameFull: Samur MK
      – PersonEntity:
          Name:
            NameFull: Anderson KC
      – PersonEntity:
          Name:
            NameFull: Munshi NC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 01
              Text: 2026 Jan 12
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2643-3249
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer discovery
              Type: main
ResultId 1